Medicines Development For Global Health

This study tests an experimental drug called dovramilast for people with moderate to severe leprosy type 2 reaction, a painful skin condition. About 45 adults will receive either 100 mg or 150 mg of dovramilast or standard treatments. The goal is to see if dovramilast can reduce …

This study tests if a new combination of drugs (moxidectin plus two others) can safely treat three common parasitic infections—lymphatic filariasis, scabies, and strongyloidiasis—in communities in Fiji. About 5,100 children and adults will receive either the new combo or a standa…